Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
Hikma Pharmaceuticals' decision not to sell its injectables business is probably one of the savviest decisions the company has taken in the last few years. The price-tag mooted was $2bn. More importantly, it put the little-known firm on many investors' radars. That unit saw its sales in the US rise
Read moreJapan-based office equipment supplier Brother Industries has agreed to acquire British printing technology company Domino Printing Sciences for £1.03bn, unleashing a 32% surge in the share price. Domino, which has operations in the UK, China, Germany, India, Sweden and the US, will continue to opera
Read more
* Sees 6 pct revenue growth in 2015 at constant currency * Sees 3 pct hit to 2015 revenue at current exchange rates * 2014 pretax profit rises 21 pct to $362 mln * Full-year revenue up 9 pct at $1.49 bln * Shares fall as much as 8 pct (Adds analyst comments and share mov
Read moreStrong performances in Hikma Pharmaceuticals' injectable drug business drove the company's annual pre-tax higher by over 20%, though a warning about the impact of the US dollar on 2015 revenues was perhaps behind an initial fall in the shares. The Jordanian drugmaker reported a 21% year-on-year incr
Read moreMarch 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by strong demand for its high-margin injectible drugs, particularly in the United States. The Jordanian company, which makes and markets branded and non-branded generics and injecti
Read more
Last checked at